Metabolic syndrome, brain magnetic resonance imaging, and cognition

Diabetes Care

Volumn 33, Issue 12, 2010, Pages 2489-2495

  Cavalieri, Margherita ^a,b   Ropele, Stefan ^a   Petrovic, Katja ^a   Pluta Fuerst, Aga ^a   Homayoon, Nina ^a   Enzinger, Christian ^a   Grazer, Anja ^a   Katschnig, Petra ^a   Schwingenschuh, Petra ^a   Berghold, Andrea ^a   Schmidt, Reinhold ^a  

^a MEDICAL UNIVERSITY OF GRAZ   (Austria)

^b UNIVERSITY OF FERRARA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; C REACTIVE PROTEIN; NONSTEROID ANTIINFLAMMATORY AGENT;

ADULT; AGED; ARTICLE; BRAIN ISCHEMIA; BRAIN SIZE; COGNITIVE DEFECT; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DEMENTIA; EXECUTIVE FUNCTION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEMORY; METABOLIC SYNDROME X; MINI MENTAL STATE EXAMINATION; NEUROPSYCHOLOGICAL TEST; NUCLEAR MAGNETIC RESONANCE IMAGING; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; PSYCHOMOTOR PERFORMANCE; RISK ASSESSMENT; SEX DIFFERENCE; STROKE;

AGED; BRAIN; COGNITION; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; METABOLIC SYNDROME X; MIDDLE AGED; PROSPECTIVE STUDIES;

EID: 79951705805     PISSN: 01495992     EISSN: 19355548     Source Type: Journal    
DOI: 10.2337/dc10-0851     Document Type: Article

References (25)

1. Grundy SM, Brewer HB Jr, Cleeman JI, Smith SC Jr, Lenfant C. Definition of metabolic syndrome: report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition. Circulation 2004;109(3):433-438
2. Yaffe K, Kanaya A, Lindquist K, Simonsick EM, Harris T, Shorr RI, Tylavsky FA, Newman AB. The metabolic syndrome, inflammation, and risk of cognitive decline. JAMA 2004;292(18):2237-2242 (Pubitemid 39473161)
3. Dik MG, Jonker C, Comijs HC, Deeg DJ, Kok A, Yaffe K, Penninx BW. Contribution of metabolic syndrome components to cognition in older individuals. Diabetes Care 2007;30(10):2655-2660 (Pubitemid 47547816)
4. Vanhanen M, Koivisto K, Moilanen L, Helkala EL, Hanninen T, Soininen H, Kervinen K, Kesaniemi YA, Laakso M, Kuusisto J. Association of metabolic syndrome with Alzheimer disease: a population-based study. Neurology 2006;67(5):843-847 (Pubitemid 44394200)
5. van den Berg E, Biessels GJ, de Craen AJ, Gussekloo J, Westendorp RG. The metabolic syndrome is associated with decelerated cognitive decline in the oldest old. Neurology 2007; 69(10):979-985 (Pubitemid 47366051)
6. Laudisio A, Marzetti E, Pagano F, Cocchi A, Franceschi C, Bernabei R, Zuccala G. Association of metabolic syndrome with cognitive function: the role of sex and age. Clin Nutr 2008;27(5):747-754
7. Raffaitin C, Gin H, Empana JP, Helmer C, Berr C, Tzourio C, Portet F, Dartigues JF, Alperovitch A, Barberger-Gateau P. Metabolic syndrome and risk for incident Alzheimer's disease or vascular dementia: the Three-City Study. Diabetes Care 2009;32(1):169-174
8. Craft S, Watson GS. Insulin and neurodegenerative disease: shared and specific mechanisms. Lancet Neurology 2004;3:169-178 (Pubitemid 38229951)
9. Schmidt R, Launer LJ, Nilson L-G, Pajak A, Sans S, Berger K, Breteler M, de Ridder M, Dufouil C, Fuhrer R, Giampaoli S, Hofman A, the CASCADE Consortium. Magnetic resonance imaging of the brain in diabetes: the Cardiovascular Determinants of Dementia (CASCADE) study. Diabetes 2004;53:687-692
10. Kwon HM, Kim BJ, Lee SH, Choi SH, Oh BH, Yoon BW. Metabolic syndrome as an independent risk factor of silent brain infarction in healthy people. Stroke 2006;37(2):466-470
11. Park K, Yasuda N, Toyonaga S, Yamada SM, Nakabayashi H, Nakasato M, Nakagomi T, Tsubosaki E, Shimizu K. Significant association between leukoaraiosis and metabolic syndrome in healthy subjects. Neurology 2007;69(10):974-978 (Pubitemid 47366050)
12. Segura B, Jurado MA, Freixenet N, Falcon C, Junque C, Arboix A. Microstructural white matter changes in metabolic syndrome: a diffusion tensor imaging study. Neurology 2009;73(6):438-444
13. Schmidt R, Fazekas F, Kapeller P, Schmidt H, Hartung H. MRI white matter hyperintensities: three-year follow-up of the Austrian Stroke Prevention Study. Neurology 1999;53:132-139 (Pubitemid 29329661)
14. Schmidt R, Lechner H, Fazekas F, Niederkorn K, Reinhart B, Grieshofer P, Horner S, Offenbacher H, Koch M, Eber B, Schumacher M, Kapeller P, Freidl W, Dusek T. Assessment of cerebrovascular risk profiles in healthy persons: definition of research goals and the Austrian Stroke Prevention Study (ASPS). Neuroepidemiology 1994;13(6):308-313 (Pubitemid 24263566)
15. Fazekas F, Niederkorn K, Schmidt R, Offenbacher H, Horner S, Bertha G, Lechner H. White matter signal abnormalities in normal individuals: correlation with carotid ultrasonography, cerebral blood flow measurements, and cerebrovascular risk factors. Stroke 1988;19:1285-1288
16. Plummer D. DispImage: a display and analysis tool for medical images. Revista di Neuroradiologica 1992;5:489-495 (Pubitemid 23017719)
17. Regitz-Zagrosek V, Lehmkuhl E, Weickert MO. Gender differences in the metabolic syndrome and their role for cardiovascular disease. Clin Res Cardiol 2006;95(3):136-147
18. Desmond DW. The neuropsychology of vascular cognitive impairment: is there a specific cognitive deficit? J Neurol Sci 2004;226(1-2):3-7
19. Kodl CT, Seaquist ER. Cognitive Dysfunction and Diabetes Mellitus. Endocrine Reviews 2008;29(4):494-511
20. Geer EB, Wei Shen. Gender Differences in Insulin Resistance, Body Composition, and Energy Balance. Gend Med 2009;6(Suppl. 1):60-75
21. van Harten B, de Leeuw FE, Weinstein HC, Scheltens P, Biessels GJ. Brain imaging in patients with diabetes: a systematic review. Diabetes Care 2006;29(11):2539-2548 (Pubitemid 44912267)
22. Manolio TA, Olson J, Longstreth WT. Hypertension and cognitive function: pathophysiologic effects of hypertension on the brain. Curr Hypertens Rep 2003;5(3):255-261 (Pubitemid 38914969)
23. Yaffe K. Metabolic syndrome and cognitive disorders: is the sum greater than its parts? Alzheimer Dis Assoc Disord 2007;21(2):167-171
24. Schmidt R, Schmidt H, Curb D, Masaki K, White L, Launer L. Early inflammation and dementia: a 25-year follow-up of the Honululu-Asia Aging Study. Ann Neurol 2002;52:168-174 (Pubitemid 34810596)
25. Engelhart MJ, Geerlings MI, Meijer J, Kiliaan A, Ruitenberg A, van Swieten JC, Stijnen T, Hofman A, Witteman JC, Breteler MM. Inflammatory proteins in plasma and the risk of dementia: the Rotterdam Study. Arch Neurol 2004;61(5):668-672 (Pubitemid 38637682)